News

Avanir completed first of a two-stage pharmacokinetic study of AVP-786 in healthy subjects According to the interim data, a formulation of AVP-786 has a similar pharmacokinetic, safety and

The new software uses TLC data from 2 to 10 different TLC and includes step gradient optimization feature that helps to estimate where the individual sample components will

The studies compared the pharmacokinetic activity of rFVIIIFc for hemophilia A and rFIXFc for hemophilia B to existing standard therapies. Data from phase 3 registrational studies demonstrated that

The ultrasound contrast agent Definity is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to recover the delineation of the left

Including clinical templates and workflows for over 30 specialties, the e-MDs Solution Series can be pre-defined and modified at the point of care with automated linking of ICD

Under the collaboration, which is funded by a Wellcome Trust Seeding Drug Discovery award, Argenta will provide medicinal chemistry, computer-aided drug design and ADME/PK (absorption, distribution, metabolism and

The label will now include warnings about kidney and gall stones in addition to updated information regarding drug interaction. Interstitial nephritis, where in the spaces between the kidney

The new products include the Interactive Care Insights for Oncology, powered by Watson, in collaboration with IBM, Memorial Sloan-Kettering and WellPoint, the WellPoint Interactive Care Guide and Interactive

Pomalyst, the third drug in a class of immunomodulatory agents including lenalidomide and thalidomide, adjusts immune system of the body to destroy and inhibit the growth of cancerous